Literature DB >> 8919546

Papillary renal cell carcinoma: quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy.

C L Corless1, H Aburatani, J A Fletcher, D E Housman, M B Amin, D S Weinberg.   

Abstract

Papillary renal cell carcinoma (papillary RCC) is an uncommon histologic variant of RCC with distinct gross, microscopic, and immunohistochemical features. Recent karyotypic analyses suggest that papillary RCC differs from other types of RCC at the genetic level as well. Whereas nonpapillary (clear cell, granular cell) RCC is characterized by deletions in chromosome 3p, papillary tumors reportedly exhibit a pattern of chromosomal trisomies, typically including chromosomes 7 and 17. To further examine the relationship between overrepresentation of these chromosomes and papillary histology, archival material from 36 papillary tumors was subjected to fluorescence in situ hybridization (FISH) analysis using alpha-satellite repeat probes specific to 7 and 17. Excess signals for chromosome 17 were detected in 22 of 28 (78%) low-grade papillary tumors (Fuhrman nuclear grades 1 and 2), and in seven of eight (87%) high-grade tumors (grades 3 and 4). Correlation of chromosome 17 FISH signals with karyotypes performed on two low-grade and three high-grade tumors was excellent. Among the cases without evidence of excess chromosome 17 were three unusual papillary tumors with sclerotic and hyalinized fibrovascular cores. In two cases, comparison was made of FISH signals from multiple, separate gross nodules of tumor; concordance for trisomic 17 signals was observed in one case, but not in the other. Chromosome 7 signals were overrepresented in all seven papillary tumors examined. DNA ploidy was determined in 19 of the 36 tumors; a relationship between DNA ploidy and polysomy 7 or 17 was not apparent. To examine the possible role of chromosome 3p deletions in the development of papillary RCC, 11 cases were studied for loss of heterozygosity (LOH) at one or more loci in the region of 3p13-21. Only three of the 11 cases had LOH at these loci. The findings are discussed with respect to the development and progression of papillary RCC.

Entities:  

Mesh:

Year:  1996        PMID: 8919546     DOI: 10.1097/00019606-199603000-00009

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  11 in total

1.  Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases.

Authors:  Yves Allory; Delphine Ouazana; Eric Boucher; Nicolas Thiounn; Annick Vieillefond
Journal:  Virchows Arch       Date:  2003-04-04       Impact factor: 4.064

2.  Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up.

Authors:  Marie Dvorakova; Rajiv Dhir; Sheldon I Bastacky; Kathleen M Cieply; Marie B Acquafondata; Carol R Sherer; Tracy L Mercuri; Anil V Parwani
Journal:  Diagn Pathol       Date:  2010-05-24       Impact factor: 2.644

Review 3.  [Cytogenetic alterations in renal tumors. Applications for comparative genomic hybridization and fluorescence in situ hybridization].

Authors:  K D Mertz; J Tchinda; R Küfer; P Möller; M A Rubin; H Moch; S Perner
Journal:  Urologe A       Date:  2006-03       Impact factor: 0.639

4.  Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma.

Authors:  Stephanie N Kinney; John N Eble; Ondrej Hes; Sean R Williamson; David J Grignon; Mingsheng Wang; Shaobo Zhang; Lee Ann Baldrige; Guido Martignoni; Matteo Brunelli; Lisha Wang; Eva Comperat; Rong Fan; Rodolfo Montironi; Gregory T MacLennan; Liang Cheng
Journal:  Mod Pathol       Date:  2015-08-07       Impact factor: 7.842

5.  Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma.

Authors:  Melinda E Sanders; Rosemarie Mick; John E Tomaszewski; Frederic G Barr
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

6.  Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes.

Authors:  F Jiang; J Richter; P Schraml; L Bubendorf; T Gasser; G Sauter; M J Mihatsch; H Moch
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

7.  Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy.

Authors:  Lisha Wang; Sean R Williamson; Mingsheng Wang; Darrell D Davidson; Shaobo Zhang; Lee Ann Baldridge; Xiang Du; Liang Cheng
Journal:  Mol Cancer       Date:  2014-02-26       Impact factor: 27.401

8.  Combined Papillary Renal Cell Carcinoma with Neuroendocrine Differentiation and Mucinous Tubular and Spindle Cell Carcinoma.

Authors:  Gang Wang; Ren Yuan; Tracy Tucker; Allan B Gates; Christopher D Bellamy; Malcolm M Hayes
Journal:  Case Rep Pathol       Date:  2018-12-31

Review 9.  Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.

Authors:  Ning Yi Yap; Retnagowri Rajandram; Keng Lim Ng; Jayalakshmi Pailoor; Ahmad Fadzli; Glenda Carolyn Gobe
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

10.  Relationships between Chromosome 7 Gain, MET Gene Copy Number Increase and MET Protein Overexpression in Chinese Papillary Renal Cell Carcinoma Patients.

Authors:  Xiaolu Yin; Tianwei Zhang; Xinying Su; Yan Ji; Peng Ye; Haihua Fu; Shuqiong Fan; Yanying Shen; Paul R Gavine; Yi Gu
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.